Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
50 Cards in this Set
- Front
- Back
In what setting do cardiac arrhythmias commonly occur?
|
the presence of preexisting heart disease
|
|
Associations with antiarrhythmics?
|
anesthesia, hyperthyroidism, electrolyte disorders, and digitalis toxicity
|
|
What are the five main classes of antiarrythmic drugs?
|
Group 1 (sodium channel blockers)
Group 2 (beta-blockers) Group 3 (potassium channel blockers) Group 4 (calcium channel blockers) Group 5 (Miscellaneous) |
|
Esmolol is an example of what class of antiarrythmic?
|
beta-blocker
|
|
What are the two major mechanisms for arrhythmias?
|
abnormal automaticity and abnormal conduction
|
|
Name 6 clinically significant arrhythmias
|
atrial flutter, atrial fibrillation, atrioventricular nodal reentry, premature ventricular beats, ventricular tachycardia, ventricular fibrillation
|
|
What is torsade de pointes
|
ventricular arrhythmia often induced by antiarrhythmic and other drugs that change the shape of the action potential and prolong the QT interval
|
|
How does torsade de pointes present on an EKG
|
polymorphic ventricular tachycardia, waxing and waning QRS amplitude; associated with long QT syndrome
|
|
In the AV node, what current dominates the upstroke and the AP conduction velocity?
|
calcium
|
|
What is supraventricular tachycardia?
|
a reentrant arrhythmia that travels through the AV node; may be conducted through atrial tissue as part of the reentrant circuit
|
|
What is ventricular tachycardia?
|
associated with MI; may involve abnormal automaticity or abnormal conduction; impairs cardiac output, may turn into V Fib (emergency)
|
|
Effect of group 1A drugs on AP?
|
prolong
|
|
Class of procainamide?
|
Group 1A
|
|
Effect of group 1B on AP?
|
shorten in some cardiac tissues
|
|
Class of lidocaine?
|
Group 1B
|
|
Mechanism of action of group 1 antiarrhythmics?
|
slow or block conduction in ischemic and depolarized cells;
slow or abolish abnormal pacemakers wherever they depend on sodium channels |
|
Very selective group 1 drugs work specifically on?
|
ischemic or abnormal tissue
|
|
How do certain group 1 drugs selectively block abnormal tissue sodium channels?
|
-more effective when channel is open or in refractory period
-abnormal tissue ion channels spend more time in open state |
|
Effect of group 1C on AP?
|
none
|
|
quinidine and disopyramide class
|
Group 1A
|
|
Group 1A block which type of arrhythmias?
|
both atrial and ventricular
|
|
Full effects of group 1A drugs?
|
slow conduction velocity and ectopic pacemakers, increase AP duration and effective refractory period
|
|
Route of administration for lidocaine
|
IV or IM
|
|
Orally active 1B drug?
|
mexiletine
|
|
Lidocaine specifically affects?
|
ischemic or depolarized Purkinje and ventricular tissue (little effect on atrial tissue)
|
|
Phenytoin use as a cardiac drug?
|
reverse digitalis-induced arrhythmias
|
|
How does lidocaine work?
|
Reduces AP duration in some cells, but slows recovery of sodium channels from inactivation which does not shorten the effective refractory period
|
|
Prototype drug with group 1C actions?
|
flecainide
|
|
How do group 1C drugs work?
|
depress sodium current and markedly slow conduction velocity in atrial and ventricular cells **visible on ECG as QRS elongation
|
|
Toxicity of procainamide?
|
increased arrhythmias, hypotension, lupus-like syndrome
|
|
toxicity of quinidine
|
cinchonism, cardiac depression, GI upset, autoimmune rxns
|
|
Interaction of quinidine and digoxin?
|
reduces clearance of digoxine and may increase the serum concentration
|
|
What ionic state exacerbates cardiac tox of group 1A, 1B, and 1C drugs?
|
hyperkalemia
|
|
Treatment of overdose with group 1A drugs?
|
sodium lactate and pressor sympathomimetics
|
|
When are atrial arrhythmias responsive to lidocaine
|
only if caused by digitalis
|
|
Why is lidocaine not given orally
|
high 1st pass effect and metabolites may be cardiotoxic
|
|
Prototypic antiarrhythmic beta-blockers?
|
propranolol and esmolol
|
|
mechanism of action of group 2 antiarrhythmics?
|
cardiac beta-adrenoceptor blockade, reduction in cAMP, results in reduction of both sodium and calcium currents and suppression of abnormal pacemakers
|
|
Esmolol use exclusivity?
|
acute arrhythmias
|
|
Group 1B drugs used as prophylactics for MI patients?
|
propranolol, metoprolol, timolol
|
|
Five group 3 antiarrhythmics?
|
dofetilide, abutilide, sotalol, amiodarone, dronedarone
|
|
Mechanism of action of group 3 drugs?
|
prolongation of the Ap duration; caused by blockade of potassium channels that are responsible for the repolarization of the AP **apparent use in ECG
|
|
most important toxicity of group 3 drugs?
|
torsade de pointes
|
|
Most efficacios antiarrhythmic drug?
|
amiodarone (broad spectrum)
|
|
Amiodarone side effects?
|
microcrystalline deposits in the cornea and skin, thyroid dysfunction, paresthesias, tremor, and pulmonary fibrosis
|
|
Prototype of group 4 antiarrhythmics?
|
verapamil (diltiazem also effective)
|
|
Mechanism of group 4 drugs?
|
-work in arrhythmias that must cross calcium-dependent cardiac tissue (AV node); cause a selective depression of calcium current in tissues that require L-type calcium channels
|
|
Effect of group 4 drugs on AV conduction velocity, ERP, and PR?
|
AV: decreased
ERP: increased PR: increased |
|
In what cardiac clinical setting should group 4 drugs be avoided?
|
ventricular tachycardias
|
|
How does adenosine function as an anti-arrhythmic?
|
blocks conduction in the AV node by hyperpolarizing tissue and reducing calcium current
|